Table S1 from A Phase II Study of Durvalumab for Bacillus Calmette-Guerin (BCG) Unresponsive Urothelial Carcinoma <i>In Situ</i> of the Bladder

• DOI: 10.1158/1078-0432.24228922.v1
• Publication Date: 2023-10-02T07:20:09Z
• Authors: Roger Li; Wade J. Sexton; Jasreman Dhillon; Anders Berglund; Shreyas Naidu; Gustavo Borjas; Kyle Rose; Youngchul Kim; Xuefeng Wang; Jose R. Conejo-Ga...; Rohit K. Jain; Michael A. Poch; Philippe E. Spiess; Julio Pow-Sang; Scott M. Gilbert; Jingsong Zhang
• Keywords: Durvalumab; Carcinoma in situ; Table (database); Bacillus (shape)

&lt;p&gt;Study Representativeness Table&lt;/p&gt;